Zinc inhibits osteoclast differentiation by suppression of Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Park, Kwang Hwan ^a,c   Park, Boryung ^b   Yoon, Dong Suk ^a   Kwon, Seung Hyun ^a   Shin, Dong Min ^b   Lee, Jin Woo ^a   Lee, Hyun Gyu ^a   Shim, Jae Hyuck ^c   Park, Jeon Han ^a   Lee, Jae Myun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bone loss; Ca ssup 2+ esup oscillation; Calcineurin; NFATc1; Osteoclast; Zinc

Indexed keywords

CALCINEURIN; CALCIUM ION; COLONY STIMULATING FACTOR 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOLIPASE C GAMMA1; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE; CALCIUM; NFATC1 PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CELL LINE; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; GENE ACTIVITY; MALE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAW264.7 CELL; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; OSTEOCLAST; DRUG EFFECT;

ANIMALS; BONE MARROW CELLS; CALCINEURIN; CALCIUM; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; MICE; MONOCYTES; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; RANK LIGAND; SIGNAL TRANSDUCTION; ZINC;

EID: 84884779402     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-74     Document Type: Article

References (59)

1. Causes of age-related bone loss and bone fragility: an alternative view. Raisz LG, Seeman E, J Bone Miner Res 2001 16 1948 1952 10.1359/jbmr.2001.16.11. 1948 11697790 (Pubitemid 32995385)
2. Central control of bone formation. Takeda S, Karsenty G, J Bone Miner Metab 2001 19 195 198 10.1007/s007740170042 11368306 (Pubitemid 32499812)
3. The development and function of the skeleton and bone metastases. Rodan GA, Cancer 2003 97 726 732 10.1002/cncr.11147 12548569 (Pubitemid 36125807)
4. Inter- and intracellular signaling in secondary osteoporosis. Tanaka Y, Okada Y, Nakamura T, J Bone Miner Metab 2003 21 61 66 10.1007/s007740300010 12601568 (Pubitemid 41184302)
5. Mechanisms of bone metastasis. Roodman GD, N Engl J Med 2004 350 1655 1664 10.1056/NEJMra030831 15084698 (Pubitemid 38501167)
6. Osteoblasts and osteoclasts in bone remodeling and inflammation. Tanaka Y, Nakayamada S, Okada Y, Curr Drug Targets Inflamm Allergy 2005 4 325 328 10.2174/1568010054022015 16101541 (Pubitemid 40873119)
7. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF, Science 1994 266 443 448 10.1126/science.7939685 7939685
8. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. Kim N, Takami M, Rho J, Josien R, Choi Y, J Exp Med 2002 195 201 209 11805147 (Pubitemid 34461264)
9. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al. Dev Cell 2002 3 889 901 10.1016/S1534-5807(02)00369-6 12479813 (Pubitemid 35460788)
10. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Lee J, Kim K, Kim JH, Jin HM, Choi HK, Lee SH, Kook H, Kim KK, Yokota Y, Lee SY, et al. Blood 2006 107 2686 2693 10.1182/blood-2005-07-2798 16322470
11. MafB negatively regulates RANKL-mediated osteoclast differentiation. Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY, Kim N, Blood 2007 109 3253 3259 10.1182/blood-2006-09-048249 17158225 (Pubitemid 46572510)
12. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, et al. Nat Med 2009 15 1066 1071 10.1038/nm.2007 19718038
13. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S, Morioka H, et al. J Exp Med 2010 207 751 762 10.1084/jem.20091957 20368579
14. Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth. Fong L, Tan K, Tran C, Cool J, Scherer MA, Elovaris R, Coyle P, Foster BK, Rofe AM, Xian CJ, Bone 2009 44 1151 1162 10.1016/j.bone.2009.02.011 19254786
15. Regulation of T cell receptor signaling by activation-induced zinc influx. Yu M, Lee WW, Tomar D, Pryshchep S, Czesnikiewicz-Guzik M, Lamar DL, Li G, Singh K, Tian L, Weyand CM, et al. J Exp Med 2011 208 775 785 10.1084/jem.20100031 21422171
16. Zinc is a novel intracellular second messenger. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, Kurosaki T, Yamashita S, Tokunaga M, Nishida K, et al. J Cell Biol 2007 177 637 645 10.1083/jcb.200702081 17502426 (Pubitemid 46799835)
17. Effect of beta-alanyl-L-histidinato zinc on bone metabolism in rats with adjuvant arthritis. Segawa Y, Tsuzuike N, Itokazu Y, Tagashira E, Yamaguchi M, Biol Pharm Bull 1993 16 656 659 10.1248/bpb.16.656 8401397 (Pubitemid 23275909)
18. Skeletal response to dietary zinc in adult female mice. Dimai HP, Hall SL, Stilt-Coffing B, Farley JR, Calcif Tissue Int 1998 62 309 315 10.1007/s002239900437 9504955 (Pubitemid 28139313)
19. Relationships between usual nutrient intake and bone-mineral content of women 35-65 years of age: longitudinal and cross-sectional analysis. Freudenheim JL, Johnson NE, Smith EL, Am J Clin Nutr 1986 44 863 876 3491533 (Pubitemid 17209007)
20. Dietary intake and bone mineral density. Angus RM, Sambrook PN, Pocock NA, Eisman JA, Bone Miner 1988 4 265 277 3191284
21. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. Strause L, Saltman P, Smith KT, Bracker M, Andon MB, J Nutr 1994 124 1060 1064 8027856 (Pubitemid 24226510)
22. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, et al. Nature 2004 428 758 763 10.1038/nature02444 15085135 (Pubitemid 38508286)
23. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, et al. Nat Med 2006 12 1410 1416 17128269 (Pubitemid 44924500)
24. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, et al. Cell 2008 132 794 806 10.1016/j.cell.2007.12.037 18329366 (Pubitemid 351312796)
25. Vitamin E decreases bone mass by stimulating osteoclast fusion. Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, et al. Nat Med 2012 18 589 594 10.1038/nm.2659 22388090
26. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations. Kajiya H, Okamoto F, Nemoto T, Kimachi K, Toh-Goto K, Nakayana S, Okabe K, Cell Calcium 2010 48 260 269 10.1016/j.ceca.2010.09.010 20980052
27. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Mocsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC, Proc Natl Acad Sci USA 2004 101 6158 6163 10.1073/pnas.0401602101 15073337 (Pubitemid 38520544)
28. Capacitative calcium entry supports calcium oscillations in human embryonic kidney cells. Bird GS, Putney JW Jr, J Physiol 2005 562 697 706 10.1113/jphysiol.2004.077289 15513935 (Pubitemid 40246788)
29. Involvement of capacitive calcium entry and calcium store refilling in osteoclastic survival and bone resorption process. Mentaverri R, Kamel S, Brazier M, Cell Calcium 2003 34 169 175 10.1016/S0143-4160(03)00080-0 12810059 (Pubitemid 36798400)
30. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. Kim MS, Yang YM, Son A, Tian YS, Lee SI, Kang SW, Muallem S, Shin DM, J Biol Chem 2010 285 6913 6921 10.1074/jbc.M109.051557 20048168
31. Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Barritt GJ, Biochem J 1999 337 Pt 2 153 169 9882611 (Pubitemid 29052007)
32. Store-operated calcium entry in human neutrophils reflects multiple contributions from independently regulated pathways. Itagaki K, Kannan KB, Livingston DH, Deitch EA, Fekete Z, Hauser CJ, J Immunol 2002 168 4063 4069 11937565 (Pubitemid 34298413)
33. Inhibitory mechanism of store-operated Ca2+ channels by zinc. Gore A, Moran A, Hershfinkel M, Sekler I, J Biol Chem 2004 279 11106 11111 10.1074/jbc.M400005200 14715648 (Pubitemid 38401603)
34. Store-operated Ca2+ entry modulates sarcoplasmic reticulum Ca2+ loading in neonatal rabbit cardiac ventricular myocytes. Huang J, van Breemen C, Kuo KH, Hove-Madsen L, Tibbits GF, Am J Physiol Cell Physiol 2006 290 1572 C1582 10.1152/ajpcell.00226.2005 16421209 (Pubitemid 43830797)
35. Ca2+-dependent inactivation of a store-operated Ca2+ current in human submandibular gland cells. Role of a staurosporine-sensitive protein kinase and the intracellular Ca2+ pump. Liu X, O'Connell A, Ambudkar IS, J Biol Chem 1998 273 33295 33304 10.1074/jbc.273.50.33295 9837902 (Pubitemid 29005705)
36. Regulation of KCa current by store-operated Ca2+ influx depends on internal Ca2+ release in HSG cells. Liu X, Rojas E, Ambudkar IS, Am J Physiol 1998 275 571 C580 9688612
37. Trp1, a candidate protein for the store-operated Ca(2+) influx mechanism in salivary gland cells. Liu X, Wang W, Singh BB, Lockwich T, Jadlowiec J, O'Connell B, Wellner R, Zhu MX, Ambudkar IS, J Biol Chem 2000 275 3403 3411 10.1074/jbc.275.5.3403 10652333 (Pubitemid 30083047)
38. Role of nutritional zinc in the prevention of osteoporosis. Yamaguchi M, Mol Cell Biochem 2010 338 241 254 10.1007/s11010-009-0358-0 20035439
39. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, et al. J Exp Med 2005 202 1261 1269 10.1084/jem.20051150 16275763 (Pubitemid 41586956)
40. Zinc inhibition of calmodulin: a proposed molecular mechanism of zinc action on cellular functions. Brewer GJ, Aster JC, Knutsen CA, Kruckeberg WC, Am J Hematol 1979 7 53 60 10.1002/ajh.2830070107 159621 (Pubitemid 10241428)
41. Zinc ion binding to human brain calcium binding proteins, calmodulin and S100b protein. Baudier J, Haglid K, Haiech J, Gerard D, Biochem Biophys Res Commun 1983 114 1138 1146 10.1016/0006-291X(83)90681-2 6615509 (Pubitemid 13045381)
42. Activation of calmodulin by various metal cations as a function of ionic radius. Chao SH, Suzuki Y, Zysk JR, Cheung WY, Mol Pharmacol 1984 26 75 82 6087119 (Pubitemid 14035226)
43. Zinc deficiency decreases the activity of calmodulin regulated cyclic nucleotide phosphodiesterases in vivo in selected rat tissues. Law JS, McBride SA, Graham S, Nelson NR, Slotnick BM, Henkin RI, Biol Trace Elem Res 1988 16 221 226 10.1007/BF02797137 2484550
44. Modulation of the phosphorylation and activity of calcium/calmodulin- dependent protein kinase II by zinc. Lengyel I, Fieuw-Makaroff S, Hall AL, Sim AT, Rostas JA, Dunkley PR, J Neurochem 2000 75 594 605 10899934 (Pubitemid 30485440)
45. Reciprocity between tissue calmodulin and cAMP levels: modulation by excess zinc. Heng MK, Song MK, Heng MC, Br J Dermatol 1993 129 280 285 10.1111/j.1365-2133.1993.tb11847.x 8286225 (Pubitemid 23283999)
46. Effect of zinc on cellular levels of calmodulin and cyclic adenosine monophosphate in the adipocyte. Lin PY, Lin WH, Tsou CT, Song YM, Chen MD, Biol Trace Elem Res 2000 76 229 234 10.1385/BTER:76:3:229 11049221
47. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity. Hasegawa H, Kido S, Tomomura M, Fujimoto K, Ohi M, Kiyomura M, Kanegae H, Inaba A, Sakagami H, Tomomura A, J Biol Chem 2010 285 25448 25457 10.1074/jbc.M109.068742 20547767
48. Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-kappaB activation. Yamaguchi M, Weitzmann MN, Mol Cell Biochem 2011 355 179 186 10.1007/s11010-011-0852-z 21533765
49. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Bao B, Prasad AS, Beck FW, Snell D, Suneja A, Sarkar FH, Doshi N, Fitzgerald JT, Swerdlow P, Transl Res 2008 152 67 80 10.1016/j.trsl.2008.06.001 18674741
50. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Hie M, Tsukamoto I, Eur J Pharmacol 2011 668 140 146 10.1016/j.ejphar.2011.07.003 21806983
51. Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus. Myers SA, Nield A, Myers M, J Nutr Metab 2012 2012 173712 23304467
52. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Hirano T, Murakami M, Fukada T, Nishida K, Yamasaki S, Suzuki T, Adv Immunol 2008 97 149 176 18501770 (Pubitemid 351697819)
53. Zinc homeostasis and signaling in health and diseases: Zinc signaling. Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T, J Biol Inorg Chem 2011 16 1123 1134 10.1007/s00775-011-0797-4 21660546
54. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Beyersmann D, Haase H, Biometals 2001 14 331 341 10.1023/A:1012905406548 11831463 (Pubitemid 34066636)
55. Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5. Inoue K, Matsuda K, Itoh M, Kawaguchi H, Tomoike H, Aoyagi T, Nagai R, Hori M, Nakamura Y, Tanaka T, Hum Mol Genet 2002 11 1775 1784 10.1093/hmg/11.15.1775 12095919 (Pubitemid 34812098)
56. Expression of the zinc transporter ZIP1 in osteoclasts. Khadeer MA, Sahu SN, Bai G, Abdulla S, Gupta A, Bone 2005 37 296 304 10.1016/j.bone.2005.04.035 16005272 (Pubitemid 41160488)
57. NFAT and Osterix cooperatively regulate bone formation. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H, Nat Med 2005 11 880 885 10.1038/nm1270 16041384 (Pubitemid 41161121)
58. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Monticelli S, Rao A, Eur J Immunol 2002 32 2971 2978 10.1002/1521-4141(2002010) 32:10<2971::AID-IMMU2971>3.0.CO;2-G 12355451 (Pubitemid 35238190)
59. A new mathematical model for relative quantification in real-time RT-PCR. Pfaffl MW, Nucleic Acids Res 2001 29 45 10.1093/nar/29.9.e45 11328886